Thanks for the data! That's an interesting concept but the patient will still be subjected to some form of drug regimen. Hopefully that can be a significantly lower dose and less unpleasant side effects. That's worth keeping our fingers crossed! Kewl
hiatus said
Jun 29, 2013
I post on these guys last year. Looks like the finally have IDE approval for a safety study in the US. Hope it goes well.
Thanks for the data! That's an interesting concept but the patient will still be subjected to some form of drug regimen. Hopefully that can be a significantly lower dose and less unpleasant side effects. That's worth keeping our fingers crossed! Kewl
I post on these guys last year. Looks like the finally have IDE approval for a safety study in the US. Hope it goes well.
http://www.prnewswire.com/news-releases/aethlon-medical-announces-fda-approval-of-ide-to-treat-hepatitis-c-hcv-patients-212905971.html